What are the methods used to optimise the potential organ donor and the physiological values targeted?
System
Methods for Optimisation
Targets
Cardiovascular System
  • Use invasive haemodynamic monitoring:
    • CVC should be inserted in right IJV or SCV
    • Arterial line in Left radial or brachial artery due to order vessels are ligated
    • Cardiac output monitoring to guide fluids and vasopressor therapy if hypotensive or EF <40%
  • Correct hypovolaemia:
    • Crystalloid or colloid infusions titrated to achieve euvolaemia
    • Avoid volume overload as organs susceptible to capillary leakage
  • Correct hypotension
    • Vasopressin 1-4 units/h is first-line therapeutic agent
      • Less likely to cause metabolic acidosis or pulmonary hypertension
      • Treats diabetes insipidus
    • Reduce catecholamines and use as sparingly as possible
  • Optimise cardiac output:
    • Inotropic support may be required if cardiac index not improved with fluid therapy required
    • Dopamine (first line) or dobutamine inotropes of choice
    • Treat arrhythmias aggressively
    • Thyroid hormone replacement may improve cardiac function
  • Perform investigations where possible:
    • 12-lead ECG (to exclude Q-waves)
    • Troponin level in all cardiac arrest cases
    • Echocardiogram
  • Mean Arterial Pressure (MAP): 60-80 mmHg
  • Central Venous Pressure (CVP): 4-10 mmHg
  • Pulmonary Artery Wedge Pressure (PAWP): 10-15 mmHg
  • Heart Rate: 60-100 bpm
  • Rhythm: sinus rhythm is desirable
  • Cardiac Index (CI): >2.1L/min
  • ScvO2 : 60 %
  • Systemmic Vascular Resistance Index (SVRI): 1800 – 2400 dynes*sec/cm5/m2
Respiratory System
  • Lung recruitment maneuvers and PEEP following apnoea test
  • Continue VAP prevention measures:
    • 30-45 degrees head up tilt
    • Tight endotracheal cuff
    • Patient positioning as per unit protocol
  • Review ventilation, ensure lung protective strategy:
    • Tidal volumes 4-8 ml/kg ideal body weight
    • Optimum PEEP (5-10 cmH2O)
    • Peak inspiratory pressures limited to <30 cmH2O
    • Minimize FiO2 if lungs are to be transplanted
  • Reinstate chest physiotherapy and regular suctioning
  • If required perform bronchoscopy, bronchial lavage and toilet for therapeutic purposes
  • Avoid high extravascular lung water:
    • Early use of methylprednisolone 15 mg/kg given intravenously
    • Avoid positive fluid balance
    • Perform CXR (post recruitment procedure where possible)
  • PaO2: 10 kPa FiO2 <}0.4 as able)
  • PaCO2: 5 – 6.5 kPa (or higher as long as pH >7.25)
  • Tidal Volumes: 4-8 ml/kg ideal body weight
  • PEEP: 5-10 cmH2O
  • Peak inspiratory pressure: <30 cmH2O
Endocrine & Metabolic System
  • Correct electrolyte abnormalities:
    • Hypernatremia (associated with poor liver graft function)
    • Hypokalemia
  • Manage Diabetes Insipidus:
    • Maintain Na+ <155 mmol/L with 5% dextrose
    • Maintain urine output about 1 - 2 ml/kg/h with vasopressin 1 U bolus and 0.5 - 4.0 U/h infusion
    • If failure to control diuresis, intermittent desmopressin may be required
  • Commence early hormone replacement
    • Methylprednisolone - diminishes inflammatory response
      • 15 mg/kg to max 1g
      • Improves outcomes in lung transplant
    • No current role for T3:
      • Associated with adverse effects such as arrhythmias
  • Correct hyperglycemia:
    • Insulin infusion to maintain plasma glucose 4-10 mmol/L
    • Start at minimum 1 unit/h and add a glucose containing fluid if required
  • Correct hypothermia aiming temperature 36-37.5°C:
    • Warmed intravenous fluids
    • Warming blankets
    • Heated and humidified inspired gases
  • Stop nephrotoxic drugs
  • Temperature: 36 – 37.5°C
  • Blood glucose: 4.0 – 10.0 mmol/l
  • Urine output: 0.5 – 2.0 ml/kg/hour
Haematological System
  • Correct DIC and coagulopathy:
    • Treat with products if required
    • Avoid antifibrinolytics which may cause microthrombi
  • Maintain haemoglobin at >70 g/dL to optimise oxygen delivery
  • Ensure appropriate thromboembolic prophylaxis continued:
    • Anti-embolic stockings and sequential compression devices
    • Low molecular weight heparin